Comprehensive eye care provider specializing in cataract, glaucoma, retinal, and refractive treatments using advanced medical technology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Centre for Sight is a leading eye care provider offering a comprehensive range of ophthalmic services, including treatments for cataracts, glaucoma, retinal disorders, and refractive errors. The organization has expanded to multiple centers across various cities, equipped with modern infrastructure and advanced technology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Centre for Sight Management Team
Centre for Sight Valuations & Financials
View real-time NPM data on Centre for Sight stock including daily Centre for Sight stock price estimates, valuation history, and historical share price information. Access Centre for Sight financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Centre for Sight pricing across six independent market signals. Looking for private company due diligence data sources on Centre for Sight? Get in touch to learn more.
Similar Companies
like Centre for Sight
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Frost Giant Studios
Media & Entertainment
Independent game studio developing real-time strategy games for PC, focusing on competitive gameplay and storytelling.
Robotic Skies
Provides global maintenance, repair, and inspection services for commercial drone fleets through a network of certified service centers.
Treadwell Therapeutics
Healthcare & Life Sciences
Provides software solutions and tools to help businesses track, manage and improve their ESG performance and sustainability initiatives.
AI Medical Service
Develops AI-powered diagnostic solutions for endoscopic imaging, specializing in early detection of gastrointestinal cancers.
Sermonix Pharmaceuticals
Healthcare & Life Sciences
Biotech company developing targeted treatments for breast and ovarian cancers, specializing in innovative hormone receptor therapies.
Zing Health
Offers Medicare Advantage HMO plans that simplify enrollment and empower members to choose providers tailored to their needs.
Strata Oncology
Healthcare & Life Sciences
Provides precision medicine solutions through genomic profiling to match cancer patients with targeted therapies for improved treatment outcomes.
Agora
Delivers real-time voice, video, and data communication solutions for web and native applications worldwide.
FAQ
We have answers
Centre for Sight stock does not trade on public stock exchanges. Centre for Sight stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Centre for Sight stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Centre for Sight Stock does not trade on public stock exchanges. In order to sell Centre for Sight shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Centre for Sight does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Centre for Sight share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Centre for Sight stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Centre for Sight stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Centre for Sight stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Centre for Sight is a private company and has not had an IPO. There is currently no Centre for Sight IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Centre for Sight IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
